Materialise
Market Cap
US$996.5m
Last Updated
2020/02/19 01:42 UTC
Data Sources
Company Financials +
Executive Summary
Materialise NV provides additive manufacturing and medical software, and 3D printing services in Europe, the Americas, Europe and Africa, and the Asia-Pacific.
Rewards
Risk Analysis
Snowflake Analysis
Reasonable growth potential with mediocre balance sheet.
Similar Companies
Share Price & News
How has Materialise's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MTLS has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-4.2%
MTLS
1.4%
US Software
0.06%
US Market
1 Year Return
-1.1%
MTLS
43.7%
US Software
19.4%
US Market
Return vs Industry: MTLS underperformed the US Software industry which returned 42.3% over the past year.
Return vs Market: MTLS underperformed the US Market which returned 20.1% over the past year.
Shareholder returns
| MTLS | Industry | Market | |
|---|---|---|---|
| 7 Day | -4.2% | 1.4% | 0.06% |
| 30 Day | -0.6% | 8.2% | 1.1% |
| 90 Day | 9.0% | 19.0% | 8.9% |
| 1 Year | -1.1%-1.1% | 45.2%43.7% | 21.9%19.4% |
| 3 Year | 111.7%111.7% | 154.0%143.2% | 48.9%39.3% |
| 5 Year | 134.9%134.9% | 224.9%201.4% | 71.9%53.1% |
Price Volatility Vs. Market
How volatile is Materialise's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
Materialise (NASDAQ:MTLS) Shareholders Have Enjoyed An Impressive 148% Share Price Gain3 weeks ago | Simply Wall St
What Kind Of Shareholder Appears On The Materialise NV's (NASDAQ:MTLS) Shareholder Register?1 month ago | Simply Wall St
Is Materialise NV's (NASDAQ:MTLS) ROE Of 0.7% Concerning?Valuation
Is Materialise undervalued compared to its fair value and its price relative to the market?
1083.81x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: MTLS ($19.52) is trading above our estimate of fair value ($8.54)
Significantly Below Fair Value: MTLS is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MTLS is poor value based on its PE Ratio (1121.2x) compared to the Software industry average (52.1x).
PE vs Market: MTLS is poor value based on its PE Ratio (1121.2x) compared to the US market (18.4x).
Price to Earnings Growth Ratio
PEG Ratio: MTLS is poor value based on its PEG Ratio (15.4x)
Price to Book Ratio
PB vs Industry: MTLS is overvalued based on its PB Ratio (7x) compared to the US Software industry average (6x).
Next Steps
Future Growth
How is Materialise forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
72.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MTLS's forecast earnings growth (72.9% per year) is above the savings rate (1.7%).
Earnings vs Market: MTLS's earnings (72.9% per year) are forecast to grow faster than the US market (14.6% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MTLS's revenue (13.3% per year) is forecast to grow faster than the US market (7.6% per year).
High Growth Revenue: MTLS's revenue (13.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MTLS's Return on Equity is forecast to be low in 3 years time (7.2%).
Next Steps
Past Performance
How has Materialise performed over the past 5 years?
23.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MTLS has high quality earnings.
Growing Profit Margin: MTLS's current net profit margins (0.4%) are lower than last year (2.2%).
Past Earnings Growth Analysis
Earnings Trend: MTLS's earnings have grown significantly by 23.9% per year over the past 5 years.
Accelerating Growth: MTLS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MTLS had negative earnings growth (-78.9%) over the past year, making it difficult to compare to the Software industry average (17.1%).
Return on Equity
High ROE: MTLS's Return on Equity (0.7%) is considered low.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is Materialise's financial position?
Financial Position Analysis
Short Term Liabilities: MTLS's short term assets (€188.6M) exceed its short term liabilities (€78.3M).
Long Term Liabilities: MTLS's short term assets (€188.6M) exceed its long term liabilities (€128.9M).
Debt to Equity History and Analysis
Debt Level: MTLS's debt to equity ratio (89.2%) is considered high.
Reducing Debt: MTLS's debt to equity ratio has increased from 16.9% to 89.2% over the past 5 years.
Debt Coverage: MTLS's debt is well covered by operating cash flow (26.3%).
Interest Coverage: MTLS's interest payments on its debt are not well covered by EBIT (1.9x coverage).
Balance Sheet
Inventory Level: MTLS has a high level of physical assets or inventory.
Debt Coverage by Assets: MTLS's debt is covered by short term assets (assets are 1.5x debt).
Next Steps
Dividend
What is Materialise's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate MTLS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate MTLS's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MTLS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MTLS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MTLS's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
7.0yrs
Average management tenure
CEO
Wilfried Vancraen (57yo)
29.6yrs
Tenure
Mr. Wilfried Vancraen Founded Materialise Nv in July 1990 and has been its Chief Executive Officer and Director since July 1990.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 7.1yrs | no data | 0.13% €1.3m | |
| Founder | 29.6yrs | no data | 0.076% €753.6k | |
| Executive VP & CFO | 4.5yrs | no data | no data | |
| Executive VP & CTO | 4.1yrs | no data | 0.38% €3.8m | |
| Chief Information Officer | 1.5yrs | no data | no data | |
| VP, Chief Legal Officer & Secretary | 16.6yrs | no data | 0.055% €551.3k | |
| Vice President of Human Resources | 2.4yrs | no data | no data | |
| Executive VP of Medical & Director | 22.2yrs | no data | 0.52% €5.2m | |
| Executive Vice President of Software | 9.1yrs | no data | 0.34% €3.4m | |
| Chief Executive Officer of RapidFit NV | 7yrs | no data | no data |
7.0yrs
Average Tenure
53.5yo
Average Age
Experienced Management: MTLS's management team is seasoned and experienced (7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 7.1yrs | no data | 0.13% €1.3m | |
| Founder | 29.6yrs | no data | 0.076% €753.6k | |
| Executive VP of Medical & Director | 22.2yrs | no data | 0.52% €5.2m | |
| Independent Director | 2.7yrs | no data | no data | |
| Independent Director | 6.3yrs | no data | 0.021% €207.4k | |
| Independent Director | 13.6yrs | no data | no data | |
| Director | 1.3yrs | no data | no data | |
| Director | 9.1yrs | no data | 0.026% €263.6k | |
| Director | 13.1yrs | no data | 0.023% €226.1k | |
| Independent Director | 4.7yrs | no data | no data |
8.1yrs
Average Tenure
56yo
Average Age
Experienced Board: MTLS's board of directors are considered experienced (8.1 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.3%.
Top Shareholders
Company Information
Materialise NV's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Materialise NV
- Ticker: MTLS
- Exchange: NasdaqGS
- Founded: 1990
- Industry: Application Software
- Sector: Software
- Market Cap: US$996.462m
- Shares outstanding: 52.89m
- Website: https://www.materialise.com
Number of Employees
Location
- Materialise NV
- Technologielaan 15
- Leuven
- Flemish Brabant
- 3001
- Belgium
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| MTLS | NasdaqGS (Nasdaq Global Select) | Yes | SPON ADS EA REPSTG 1 ORD | US | USD | Jun 2014 |
| 06MA | DB (Deutsche Boerse AG) | Yes | SPON ADS EA REPSTG 1 ORD | DE | EUR | Jun 2014 |
Biography
Materialise NV provides additive manufacturing and medical software, and 3D printing services in Europe, the Americas, Europe and Africa, and the Asia-Pacific. The company’s Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design packages and 3D scanners. This segment serves 3D printing machine original equipment manufacturers; manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. Its Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The company’s Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. It has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Global Orthopaedic Technology Pty Ltd; Limacorporate Spa; Mathys AG; Howmedica Osteonics Corp.; and Corin Ltd., as well as a partnership with Sigma Labs, Inc. The company was founded in 1990 and is headquartered in Leuven, Belgium.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/02/19 01:42 |
| End of Day Share Price | 2020/02/18 00:00 |
| Earnings | 2019/09/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.